Pinnow Cole's Form 4 filing
Cogent Biosciences, Inc. (COGT) · filed Jan 15, 2025
- Accession no.
- 0000950170-25-005630
- Filed
- Jan 15, 2025
- Trade date
- Jan 14, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $332.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pinnow ColeCIK 0002024135 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2025 | Common Stock | PPurchaseAcquired | +43,750 | $7.60 | +$332,500 | 45,848 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.